1. World Health Organization. WHO recommendation on routes of oxytocin administration for the prevention of postpartum haemorrhage after vaginal birth. 2020 https://www.who.int/publications/i/item/9789240013926
2. Westhoff G, Cotter AM, Tolosa JE. Prophylactic oxytocin for the third stage of labour to prevent post partum haemorrhage (Review). 2013; 10. DOI: 10.1002/14651858.CD001808.pub2.
3. Kementerian Kesehatan Republik Indonesia. Buku Saku Pelayanan Kesehatan Ibu di Fasilitas Kesehatan Dasar dan Rujukan. Kemenkes RI. 2013
4. Kuzume A, Sugimi S, Suga S, et al. The Routine Use of Prophylactic Oxytocin in the Third Stage of Labor to Reduce Maternal Blood Loss. J Pregnancy. 2017; 2017:3274901.
5. Vallera C, Choi LO, Cha CM, Hong RW. Uterotonic medications oxytocin, methylergonovine, carboprost, misoprostol. Anesthesiology Clin. 2017. http://dx.doi.org/10.1016/j.anclin.2017.01.007
6. Vogel JP, Williams M, allos I, Althabe F, Oladapo OT. WHO recommendations on uterotonic for post partum haemorrhage prevention: what works, and which one. BMJ Global Health. 2019;4:e001466.
7. Stanton CK, Newton S, Mullany LC, Cofie P, Agyemang CT, Adiibokah E. Effect on post partum haemorrhage of prophylactic oxytocin (10IU) by injection by community health officers in Ghana: a community based, clustered randomized trial. PLOS Medicine. 2013;10(10): e1001524.
8. Adnan N, Trant RC, McCormick C, Boland F, Murphy DJ. Intramuscular versus intravenous oxytocin to prevent post partum haemorrhage at vaginal delivery: randomised controlled trial. BMJ. 2018.
9. Charles D, Anger H, Dabash R, et al. Intramuscular injection, intravenous infusion, and intravenous bolus of oxytocin in the third stage of labor for prevention of postpartum hemorrhage: a three-arm randomized control trial. BMC Pregnancy and Childbirth, 2019. 19(1). doi:10.1186/s12884-019-2181-2
10. Oladapo OT, Okusanya BO, Abalos E, et al. Intravenous versus intramuscular prophylactic oxytocin for the third stage of labour. Cochrane Database Syst Rev. 2020 Nov 9;11(11):CD009332.